GLP-1 Drug Shortages and Compounding
July 2024
IPD has released a new podcast episode, “GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s.
Key topics include the significant shortages of GLP-1 drugs like Wegovy, Zepbound, and Ozempic, the rise of drug compounding as a response to these shortages, regulatory challenges and safety concerns with compounded GLP-1 drugs, and more.
Content on this site is proprietary to IPD Analytics. By receiving this sample you are agreeing to refrain from any unauthorized use, including uploading or inputting into AI tools or large language models for any purpose, is strictly prohibited.